Tuberculosis preventive treatment completion in indigenous vs. non-indigenous populations in the Brazilian Amazon: a retrospective cohort study (2019–2023)

TB preventive treatment (TPT) is crucial for preventing the progression from TB infection (TBI) to active disease, particularly among vulnerable populations such as indigenous people. Although shorter regimens have improved adherence, evidence from real-world programmatic settings is limited. This study compared TPT completion rates between indigenous and non-indigenous populations in the Brazilian Amazon. We conducted a retrospective cohort study using data from the IL-TB system (2019–2023) in Amazonas, Brazil. Individuals who initiated TPT were stratified by race. The primary outcome was TPT completion. Multivariate logistic regression identified factors associated with completion, adjusting for sociodemographic, clinical, and operational variables. Of the 4,887 individuals (non-indigenous = 4,666; indigenous = 221), 79.6% completed TPT. Completion was higher among indigenous individuals (90.9%) than among non-indigenous individuals (79.1%) (p < 0.001). In the adjusted analysis, indigenous race (OR: 2.4; 95% CI: 1.49–4.06), shortened TPT regimens (OR: 2.36; 95% CI: 2.04–2.73), TBI confirmed by TST/IGRA (OR: 1.57; 95% CI: 1.06–1.65), indication of TPT for PLHIV (OR: 1.31; 95% CI: 1.04–2.73) and receiving TPT in health facilities outside the capital (OR: 2.03; 95% CI: 1.49–2.82) were positively associated with completion of TPT. Foreign nationality (OR: 0.28; 95% CI: 0.18–0.44) and receiving TPT in referral hospitals/specialist services—not exclusive to PCH (OR: 0.79; 95% CI: 0.66–0.94)—were negatively associated with such outcomes. Among non-indigenous individuals, associations mirrored those in the overall population. Among indigenous individuals, only the shortened regimen was significantly associated with completion of TPT (OR: 5.75; 95% CI: 1.78–23.4), although this estimate should be interpreted with caution, given the small subgroup size and wide confidence interval. In this Amazon cohort, TPT completion was greater among indigenous individuals and was associated with shortened regimens and facilities outside the state capital. These patterns suggest that expanding shortened regimens and PHC-based access beyond capital may support adherence in high-burden, inequity-affected settings; however, the programmatic impact should be confirmed in prospective or quasi-experimental evaluations.

Authors

Institutions

Publication Details

Journal
BMC Public Health
Published
2025-12-02
DOI
https://doi.org/10.1186/s12889-025-25177-8
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tuberculosis preventive treatment completion in indigenous vs. non-indigenous populations in the Brazilian Amazon: a retrospective cohort study (2019–2023)

Bruno B. Andrade, Moreno Magalhães de Souza Rodrigues, Renata Spener-Gomes, Izabella Picinin Safe et al.
BMC Public Health
Tuberculosis Research and Epidemiology
article

Tuberculosis preventive treatment completion in indigenous vs. non-indigenous populations in the Brazilian Amazon: a retrospective cohort study (2019–2023)

Bruno B. Andrade, Moreno Magalhães de Souza Rodrigues, Renata Spener-Gomes, Izabella Picinin Safe, Beatriz Barreto‐Duarte, Klauss Villalva-Serra, Marcelo Cordeiro‐Santos, Lívia Assis, Leandro Sousa Garcia, Júlia de Assis Pinheiro, Djane Clarys Baia-da-Silva
article en

Abstract

TB preventive treatment (TPT) is crucial for preventing the progression from TB infection (TBI) to active disease, particularly among vulnerable populations such as indigenous people. Although shorter regimens have improved adherence, evidence from real-world programmatic settings is limited. This study compared TPT completion rates between indigenous and non-indigenous populations in the Brazilian Amazon. We conducted a retrospective cohort study using data from the IL-TB system (2019–2023) in Amazonas, Brazil. Individuals who initiated TPT were stratified by race. The primary outcome was TPT completion. Multivariate logistic regression identified factors associated with completion, adjusting for sociodemographic, clinical, and operational variables. Of the 4,887 individuals (non-indigenous = 4,666; indigenous = 221), 79.6% completed TPT. Completion was higher among indigenous individuals (90.9%) than among non-indigenous individuals (79.1%) (p < 0.001). In the adjusted analysis, indigenous race (OR: 2.4; 95% CI: 1.49–4.06), shortened TPT regimens (OR: 2.36; 95% CI: 2.04–2.73), TBI confirmed by TST/IGRA (OR: 1.57; 95% CI: 1.06–1.65), indication of TPT for PLHIV (OR: 1.31; 95% CI: 1.04–2.73) and receiving TPT in health facilities outside the capital (OR: 2.03; 95% CI: 1.49–2.82) were positively associated with completion of TPT. Foreign nationality (OR: 0.28; 95% CI: 0.18–0.44) and receiving TPT in referral hospitals/specialist services—not exclusive to PCH (OR: 0.79; 95% CI: 0.66–0.94)—were negatively associated with such outcomes. Among non-indigenous individuals, associations mirrored those in the overall population. Among indigenous individuals, only the shortened regimen was significantly associated with completion of TPT (OR: 5.75; 95% CI: 1.78–23.4), although this estimate should be interpreted with caution, given the small subgroup size and wide confidence interval. In this Amazon cohort, TPT completion was greater among indigenous individuals and was associated with shortened regimens and facilities outside the state capital. These patterns suggest that expanding shortened regimens and PHC-based access beyond capital may support adherence in high-burden, inequity-affected settings; however, the programmatic impact should be confirmed in prospective or quasi-experimental evaluations.

BMC Public HealthVol. 26(1)
Universidade Federal de Santa Catarina (BR), Fundação de Medicina Tropical (BR), Instituto de Pesquisas Tecnológicas (BR), Universidade Nilton Lins (BR), Universidade do Estado do Amazonas (BR), Secretaria Municipal de Saúde (BR), Universidade Salvador (BR), Fundação Oswaldo Cruz (BR), Universidade Federal do Amazonas (BR)
Openalex Percentile: Top 56%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.